LR20062
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LR20062, covering 2024-10-01 to 2024-10-01. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age [Phase 2]